The convergence of unbiased spatial analytics and explainable AI ushers in a new era of precision pathology. The novel insights from our platforms reveal the existence of intermediate cell types and their functional states as well as communications between cells. Our solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. info@spintellx.com
Looking for a particular SpIntellx employee's phone or email?
The SpIntellx annual revenue was $3 million in 2026.
S. Chennubhotla is the Co-founder, President, Chief Technology Officer of SpIntellx.
1 people are employed at SpIntellx.
SpIntellx is based in Pittsburgh, Pennsylvania.
The NAICS codes for SpIntellx are [621, 62151, 62, 6215].
The SIC codes for SpIntellx are [80, 807].